GEUSENS, Piet

Email Alert RSS Feed

Profile

Full Name
GEUSENS, Piet
Email
piet.geusens@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Results 233-261 of 446 (Search time: 0.013 seconds).

show all
Issue DateTitleContributor(s)TypeCat.
2332007Secondary fracture prevention measures in orthopedic wards in BelgiumDevogelaer, J.; Boutsen, Y.; De Clercq, L.; Poriau, S.; GEUSENS, Piet; Goemaere, S.Journal ContributionM
2342006Clinical risk evaluation contributes to case finding and diagnosis of osteoporosis in postmenopausal women.GEUSENS, Piet; Dumitrescu, B; Cloet, A; VANHOOF, JohanJournal ContributionM
2352006The safety of infliximab, combined with background treatments, among patients with rheumatoid arthritis and various comorbidities: A large, randomized, placebo-controlled trialWesthovens, R.; Yocum, D.; Han, J.; Berman, A.; Strusberg, I.; GEUSENS, Piet; Rahman, M.Journal ContributionA1
2362006Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritisvan Staa, T.; GEUSENS, Piet; Bijlsma, J.; Leufkens, H.; Cooper, C.Journal ContributionA1
2372006The Evaluation of the Patient for Osteoporosis: Case Finding Using Diagnostic Tests for Treatment InterventionGEUSENS, PietBook SectionB2
2382006The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destructionGEUSENS, Piet; Landewe, R.; Garnero, P.; Chen, D.; Dunstan, C.; Lems, W.; STINISSEN, Piet; VAN DER HEIJDE, Desiree; van der Linden, S.; Boers, M.Journal ContributionA1
2392006Determinants of hyperkyphosis in patients with ankylosing spondylitis.Vosse, D.; VAN DER HEIJDE, Desiree; Landewé, R.; GEUSENS, Piet; Mielants, H.; Dougados, M.; van der Linden, S.Journal ContributionA1
2402006Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparisonCombe, B.; Codreanu, C.; Fiocco, U.; Gaubitz, M.; GEUSENS, Piet; Kvien, T.; Pavelka, K;; Sambrook, P.; Smolen, J.; Waydula, J.; Fatenejad, S.Journal ContributionA1
2412006Sustained improvement in clinical measures of psoriatic arthritis in infliximab-treated patients: 1 year results from impact 2Kavanaugh, A.; Antoni, C.; Krueger, G. G.; Gladman, D. D.; Birbara, C.; Boling, E.; Siegel, E.; Halter, D.; GEUSENS, Piet; De Vlam, K.; Kirkham, B.; Beutler, A.; Guzzo, C.; Zhou, B.; Dooley, L. T.; Mease, Philip J.Journal ContributionM
2422006"Allegory of the world": the ankylosed back as a metaphor for coping in daily life.Boonen, A.; van der Linden, S.; GEUSENS, Piet; Vosse, D.Journal ContributionM
2432006Partial prevention of long-term femoral bone loss in aged ovariectomized rats supplemented with choline-stabilized orthosilicic acidCalomme, M.; GEUSENS, Piet; Demeester, N.; Behets, G.; D'Haese, P.; Sindambiwe, J.; Van Hoof, V.; VAN DEN BERGHE, DavidJournal ContributionA1
2442006Prevalence and annual incidence of vertebral fractures in patients with ankylosing spondylitisFeldtkeller, E.; Vosse, D.; GEUSENS, Piet; van der Linden, S.Journal ContributionA1
2452006Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.Lems, W.; Lodder, M.; Lips, P.; Bijlsma, J.; GEUSENS, Piet; Schrameijer, N.; van de Ven, C.; Dijkmans, B.Journal ContributionA1
2462006Risk factors for falls within the first 3 months after a fracture.GEUSENS, Piet; Helden, SV; Wyers, C; Dagnelie, PC; Pijpers, E; Willems, G; Brink, P; Linden, SV; Nieuwenhuijzen-Kruseman, AJournal ContributionM
2472006Secondary osteoporosis in patients with a recent clinical fracture.Dumitrescu, B; von Helden, S; Nieuwenhuijzen-Kruseman, A; Wyers, C; van der Linden, S; GEUSENS, PietJournal ContributionM
2482006Risk of new clinical fractures within 2 years following a fracturevan Helden, S.; Cals, J.; Kessels, F.; Brink, P.; Dinant, G-J.; GEUSENS, PietJournal ContributionA1
2492006Results of a 3-month randomized trial to examine week-by-week effects of monthly ibandronate on biochemical markers of bone resorptionKung, AWC; Rovayo, R; GEUSENS, Piet; Walliser, J; Verbruggen, N; Shivaprakash, M; Wehren, LE; Melton, MEJournal ContributionM
2502006Differing effects on hip and nonspine fracture risk reduction among N-containing bisphosphonates: Review and meta-analysisLiberman, UA; Hochberg, MC; GEUSENS, Piet; Ross, PDJournal ContributionM
2512006Review and evaluation of the Dutch guidelines for osteoporosisGEUSENS, Piet; Lems, W.; Verhaar, H.; Leusink, G.; Goemaere, S.; Zmierczack, H.; Compston, J.Journal ContributionA1
2522006Hip and non-spine fracture risk reductions differ among antiresorptive agents: Evidence from randomised controlled trials.Liberman, U.; Hochberg, M.; GEUSENS, Piet; Shah, A.; Lin, Jie; Chattopadhyay, A.; Ross, P.Journal ContributionA1
2532006A simple clinical score for estimating the long-term risk of fracture in post-menopausal womenvan Staa, T.; GEUSENS, Piet; Kanis, J.; Leufkens, H.; Gehlbach, S.; CooperJournal ContributionA1
2542006Fractures, bone mineral density and bone turnover in a Dutch sarcoidosis populationHeijckmann, AC; Huijberts, MSP; De Vries, J; Wolffenbuttel, BHR; Drent, M; GEUSENS, PietJournal ContributionM
2552006Reducing hip fractures in an at-risk, elderly populationMasud, T.; GEUSENS, Piet; Barton, I.; McClung, MichaelJournal ContributionM
2562006Timing and risk factors for clinical fractures among postmenopausal women: a 5-year prospective studyvan Geel, A.; GEUSENS, Piet; Nagtzaam, I.; Schreurs, C.; van der Voort, D.; Rinkens, P.; Kester, A.; Dinant, G-J.Journal ContributionA1
2572006Modulation of biomarkers of inflammation and bone turnover and associations with bone mineral density in ankylosing spondylitis (AS) patients treated with infliximabVisvanathan, S.; Deodhar, A.; Braun, J.; VAN DER HEIJDE, Desiree; Yan, S.; Gathany, T.; GEUSENS, Piet; Williamson, P.; Wagner, C.Journal ContributionM
2582005Infliximab therapy results in sustained improvement in functional status and quality of life in patients with psoriatic arthritis - Results from the IMPACT 2 study.Kavanaugh, A; Antoni, C.E.; Krueger, GG; GEUSENS, Piet; e Vlam, K; Birbara, C; Beutler, A; Zhou, B; Dooley, LT; Guzzo, C; Wu, Y; Bala, M.; Gladman, DJournal ContributionM
2592005Improvement in-clinical measures of psoriatic arthritis in infliximab-treated patients: 1 year results from IMPACT 2.Kavanaugh, A; Antoni, C.E.; Krueger, GG; Gladman, D; Birbara, C; Boling, EP; Siegel, EL; Halter, DG; de Vlam, K; Kirkham, B; Beutler, A; Guzzo, C; Zhou, B; Dooley, LT; Mease, Philip J.; GEUSENS, PietJournal ContributionM
2602005Efficacy and Safety of Infliximab in Patients With Ankylosing SpondylitisVAN DER HEIJDE, Desiree; Dijkmans, B.; GEUSENS, Piet; Sieper, J.; DeWoody, K.; Williamson, P.; Braun, J.Journal ContributionA1
2612005Treatment with infliximab is associated with "Major clinical response" in psoriatic arthritis patients treated with infliximab: Analysis of two double-blind placebo controlled trials.Kavanaugh, A; Krueger, GG; Birbara, C; Halter, D; de Vlam, K; Zhou, B; Dooley, L; Guzzo, C; Bala, M.; Beutler, A; Antoni, C.; GEUSENS, PietJournal ContributionM
show all